Among prostate cancer patients under active surveillance, low testosterone levels were associated with a statistically significant increased risk of "extreme" progression to grade group 3 or higher ...

A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced prostate cancer, according to a phase II clinical trial conducted at Kurume ...

The 2026 European Association of Urology (EAU) annual meeting featured an advancing prognostics and therapeutics in metastatic prostate cancer session and a presentation by Dr. Rodrigo España Navarro ...

The 2026 European Association of Urology (EAU) annual meeting featured an advancements in metastatic castration resistant prostate cancer (mCRPC) therapy session and a presentation by Dr. Giulio ...

Cancer death rates in the UK have hit a record low, but the picture is more complicated than the headline figure suggests.

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...

TEM advances precision oncology as studies validate IPS, PurIST and xF+ diagnostics, highlighting stronger guidance for cancer therapy and biomarker detection.

New molecular insights into the link between hepatocellular carcinoma and intratumoral fibrosis could lead to better ...

Global evidence is mounting that personalised exercise programmes can boost confidence and wellbeing for people undergoing cancer treatment, ease ...

Proposed combination with Clywedog Therapeutics Inc. (“Clywedog”) to create a differentiated company focusing on clinical metabolic and ...

Market has emerged as a rapidly expanding segment within the oncology diagnostics and liquid biopsy landscape. Circulating Tumor Cells are cancerous cells that detach from primary or metastatic tumors ...

Clinically low testosterone can lead to a range of issues, including low energy, depressed mood, and brain fog, and it can be treated with TRT. However, a growing number of men are turning to ...